prax-628
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Dec 11, 2024 (NCT06999902)
Timeline
Indications
Mechanism of action
- UnclearINHIBITOR
Unclear inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07287163 | Phase 3 | Oct 27, 2025 | Praxis Biologics |
| NCT06840925 | Phase 1 | Mar 24, 2025 | Praxis Biologics |
| NCT06908356 | Phase 2 | Jan 10, 2025 | Praxis Biologics |
| NCT06999902 | Phase 2/Phase 3 (Phase 3) | Dec 11, 2024 | Praxis Biologics |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Praxis Biologics | For profit | 4 | 4 | 3 | 2024 |
1 organizations
Page 1 / 1